PROPERDIN- AND NEPHRITIC FACTOR-DEPENDENT C3 CONVERTASES: REQUIREMENT OF NATIVE C3 FOR ENZYME FORMATION AND THE FUNCTION OF BOUND C3B AS PROPERDIN RECEPTOR. = C3 CONVERTASES DEPENDANT DE LA PROPERDINE ET DU FACTEUR NEPHRITIQUE: NECESSITE DE C3 NATIF POUR LA FORMATION DE L'ENZYME, ET LA FONCTION DU C3B LIE COMME RECEPTEUR DE PROPERDINESCHREIBER RD; MEDICUS RG; GOTZE O et al.1975; J. EXPER. MED.; U.S.A.; DA. 1975; VOL. 142; NO 3; PP. 760-772; BIBL. 1 P. 1/2Article

COMPLEMENT ACTIVATION IN SEMISOLID MEDIA: INSOLUBILIZATION OF ALTERNATIVE PATHWAY CONVERTASES IN AGAR GELS WITH C3 NEPHRITIC FACTOR-CONTAINING SERA.MOHAMMED AMIN ARNAOUT; DAVIS AE III; ROSEN FS et al.1977; J. IMMUNOL.; U.S.A.; DA. 1977; VOL. 119; NO 4; PP. 1316-1320; BIBL. 24 REF.Article

THE INCORPORATION OF C3 NEPHRITIC FACTOR (C3NEF) INTO A STABILIZED C3 CONVERTASE, C3BBB (C3NEF), AND ITS RELEASE AFTER DECAY OF CONVERTASE FUNCTION.DAHA MR; AUSTEN KF; FEARON DT et al.1977; J. IMMUNOL.; U.S.A.; DA. 1977; VOL. 119; NO 3; PP. 812-817; BIBL. 19 REF.Article

C3 NEPHRITIC FACTOR (C3NEF): STABILIZATION OF FLUID PHASE AND CELL-BOUND ALTERNATIVE PATHWAY CONVERTASEDAHA MR; FEARON DT; AUSTEN KF et al.1976; J. IMMUNOL.; U.S.A.; DA. 1976; VOL. 116; NO 1; PP. 1-7; BIBL. 29 REF.Article

IGG SUBCLASS STUDIES OF C3 NEPHRITIC FACTORDAVIS AE III; GELFAND EW; SCHUR PH et al.1978; CLIN. IMMUNOL. IMMUNOPATHOL.; USA; DA. 1978; VOL. 11; NO 1; PP. 98-101; BIBL. 16 REF.Article

FORMATION IN THE PRESENCE OF C3 NEPHRITIC FACTOR (C3NEF) OF AN ALTERNATIVE PATHWAY C3 CONVERTASE CONTAINING UNCLEAVED B.DAHA MR; FEARON DT; AUSTEN KF et al.1976; IMMUNOLOGY; G.B.; DA. 1976; VOL. 31; NO 5; PP. 789-795; BIBL. 1 P.Article

BIOLOGICAL SIGNIFICANCE OF THE C3 NEPHRITIC FACTOR IN MEMBRANOPROLIFERATIVE GLOMERULONEPHRITISSCHENA FP; PERTOSA G; STANZIALE P et al.1982; CLIN. NEPHROL.; ISSN 0301-0430; DEU; DA. 1982; VOL. 18; NO 5; PP. 240-246; BIBL. 2 P.Article

DESCRIZIONE DI UN TEST QUANTITATIVO PER IL DOSAGGIO DEL FATTORE NEFRITICO = DESCRIPTION D'UN TEST QUANTITATIF POUR LE DOSAGE DU FACTEUR NEPHRITIQUEPISCITELLI M; VOX E; PERTOSA G et al.1978; FOLIA ALLERGOL. IMMUNOL. CLIN.; ITA; DA. 1978; VOL. 25; NO 4; PP. 357-361; ABS. ENG; BIBL. 9 REF.Article

SERUM FACTORS ACTIVATING THE ALTERNATIVE COMPLEMENT PATHWAY IN AUTOIMMUNE DISEASE: DESCRIPTION OF TWO DIFFERENT FACTORS FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUSARROYAVE CM; WILSON MR; TAN EM et al.1976; J. IMMUNOL.; U.S.A.; DA. 1976; VOL. 116; NO 3; PP. 821-826; BIBL. 34 REF.Article

HETEROGENEITY OF NEPHRITIC FACTOR AND ITS IDENTIFICATION AS AN IMMUNOGLOBULIN.DAVIS AE III; ZIEGLER JB; GELFAND EW et al.1977; PROC. NATION. ACAD. SCI. U.S.A.; U.S.A.; DA. 1977; VOL. 74; NO 9; PP. 3980-3983; BIBL. 32 REF.Article

Protection of the classical and alternative complement pathway C3 couvertases, stabilized by nephritic factors, from decay by the human C3b receptorFISCHER, E; KAZATCHKINE, M. D; MECARELLI-HALBWACHS, L et al.European journal of immunology. 1984, Vol 14, Num 12, pp 1111-1114, issn 0014-2980Article

RECURRENCE OF DENSE DEPOSITS IN TRANSPLANTED KIDNEY. II: SERUM COMPLEMENT AND NEPHRITIC FACTOR PROFILESLEIBOWITCH J; HALBWACHS L; WATTEL S et al.1979; KIDNEY INTERNATION.; DEU; DA. 1979; VOL. 15; NO 4; PP. 396-403; BIBL. 27 REF.Article

THE IMMUNOGLOBULIN NATURE OF NEPHRITIC FACTOR (NEF).SCOTT DM; AMOS N; SISSONS JGP et al.1978; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1978; VOL. 32; NO 1; PP. 12-24; BIBL. 27 REF.Article

TRANSFER OF C3 NEPHRITIC FACTOR FROM MOTHER TO FETUS. IS C3 NEPHRITIC FACTOR IGG.DAVIS AE III; MOHAMED AMIN ARNAOUT; ALPER CA et al.1977; NEW ENGL. J. MED.; U.S.A.; DA. 1977; VOL. 297; NO 3; PP. 144-145; BIBL. 19 REF.Article

IDIOPATHIC RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS WITH C3 NEPHRITIC FACTOR AND HYPOCOMPLEMENTEMIADAVIS CA; MCADAMS AJ; WYATT RJ et al.1979; J. PEDIATR.; USA; DA. 1979; VOL. 94; NO 4; PP. 559-563; BIBL. 20 REF.Article

LE FACTEUR NEPHRITIQUE: DOSAGE ET TENTATIVE D'ISOLEMENT.COURTOIS FREYRIA AM.1976; LYON; L'HERMES; DA. 1976; PP. 1-98; BIBL. 2 P. 1/2; (THESE DOCT. 3E. CYCLE, SPEC. BIOCHIM.; CLAUDE BERNARD-LYON I)Thesis

Quantitation of C4 nephretic factor by an enzyme-linked immunosorbent assaySEINO, J; KINOSHITA, Y; YOSHINAGA, K et al.Journal of immunological methods. 1990, Vol 128, Num 1, pp 101-108, issn 0022-1759Article

MOLECULAR BIOLOGY AND CHEMISTRY OF THE ALTERNATIVE PATHWAY OF COMPLEMENTMUELLER EBERHARD HJ; SCHREIBER RD.1980; ADV. IMMUNOL.; ISSN 0065-2776; USA; DA. 1980; VOL. 29; PP. 1-53; BIBL. 8 P.Article

ACTIVATION OF THE CLASSICAL PATHWAY OF COMPLEMENT BY THE CZNEF-STABILIZED CELL-BOUND AMPLIFICATION CONVERTASEDAHA MR; VANES LA.1979; J. IMMUNOL.; USA; DA. 1979; VOL. 122; NO 3; PP. 801-805; BIBL. 28 REF.Article

DISORDERS OF THE COMPLEMENT SYSTEM IN LIPODYSTROPHY.IPP MM; MINTA JO; GELFAND EW et al.1977; CLIN. IMMUNOL. IMMUNOPATHOL.; U.S.A.; DA. 1977; VOL. 7; NO 2; PP. 281-287; BIBL. 29 REF.Article

C3 nephritic factor protects bound C3bBb from cleavage by factor I and human erythrocytesMOLD, C; MEDOF, M. E.Molecular immunology. 1985, Vol 22, Num 5, pp 507-512, issn 0161-5890Article

Neutralising antibodies against C3NeF in intravenous immunoglobulinBACCHI, V. F; MAILLET, F; BERLAN, L et al.Lancet (British edition). 1992, Vol 340, Num 8810, pp 63-64, issn 0140-6736Article

ETUDE IMMUNOGENETIQUE D'UNE FAMILLE ATTEINTE D'OEDEME ANGIONEUROTIQUE HEREDITAIRE.MICHEL FB; SEIGNALET C; BERTHOUX FC et al.1978; REV. FR. MAL. RESP.; FR.; DA. 1978; VOL. 6; NO 1; PP. 111-117; ABS. ANGL.; BIBL. 23 REF.Article

METABOLISM OF THE FIFTH COMPONENT OF COMPLEMENT AND ITS RELATION TO METABOLISM OF THE THIRD COMPONENT, IN PATIENTS WITH COMPLEMENT ACTIVATION.SISSONS JGP; LIEBOWITCH J; AMOS N et al.1977; J. CLIN. INVEST.; U.S.A.; DA. 1977; VOL. 59; NO 4; PP. 704-715; BIBL. 32 REF.Article

Isolation and characterization of nephritogenic antigen from bovine glomerular basement membraneSADO, Y; WATANABE, K; OKIGAKI, T et al.Biochimica et biophysica acta. 1984, Vol 798, Num 1, pp 96-102, issn 0006-3002Article